Italian Registry of Allergen ImmunoTherapy
Recruiting now
Conditions studied: Allergic Respiratory Disease
In brief
RIAIT (Italian Registry of Allergy Immunotherapy) is a multicenter observational study that aims to prospectively collect the most extensive data available on Italian patients using AIT for respiratory allergies (rhinoconjunctivitis and/or asthma) in a real-life context, through a network of allergy centers with specific interest and expertise in the management of allergic respiratory patients.
Key facts
- Study ID
- NCT06499480
- Run by
- Società Italiana di Allergologia, Asma e Immunologia Clinica
- People needed
- 5000
- Starts
- 2024-05-01
- Expected to finish
- 2035-12-31
- Last updated by the study team
- 2025-03-06
Who can join
Age: 1 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 1 year
- Confirmed diagnosis of allergic rhinoconjunctivitis and/or allergic asthma according to EAACI 2019 guidelines.
- Having been followed by the recruiting center for at least one month: this is considered necessary to establish that the patients are truly affected by allergic respiratory disease and are eligible for allergen-specific immunotherapy; in this period, screening tests are carried out to exclude and/or confirm concomitant diseases (comorbidities). In fact, according to the aforementioned EAACI guidelines, a patient can be defined as truly eligible for allergen-specific immunotherapy only after a preliminary phase in which the patient is treated with symptomatic therapy; this observation period allows a correct evaluation of the real adherence and response to therapy, as well as the identification and appropriate treatment of any comorbidity and the possible elimination of aggravating factors.
- Having received the prescription of any of the available AIT products in Italy, irrespectively of the selected allergens and the administration route and schedule.
You may not qualify if…
- There will no be exclusion criteria, in order to allow a real-life vision of the characteristics of these patients eligible for or treated with allergen-specific immunotherapy.
Where it is running
- Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital, Rozzano, Italy — Rozzano, Milano, Italy (enrolling)
- Azienda Ospedaliera Universitaria Istituto di Ricovero e Cura a Carattere Scientifico — Florence, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.